Concorde Asset Management, LLC Zoetis Inc. Transaction History
Concorde Asset Management, LLC
- $149 Million
- Q1 2024
A detailed history of Concorde Asset Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Concorde Asset Management, LLC holds 2,022 shares of ZTS stock, worth $354,719. This represents 0.23% of its overall portfolio holdings.
Number of Shares
2,022
Previous 2,027
0.25%
Holding current value
$354,719
Previous $400,000
14.5%
% of portfolio
0.23%
Previous 0.26%
Shares
20 transactions
Others Institutions Holding ZTS
# of Institutions
1,861Shares Held
416MCall Options Held
1.13MPut Options Held
1.81M-
Vanguard Group Inc Valley Forge, PA40.7MShares$7.15 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.7MShares$6.44 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$3.43 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$2.83 Billion2.46% of portfolio
-
Bank Of America Corp Charlotte, NC14MShares$2.45 Billion0.22% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $82.1B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...